Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.27 USD | +3.25% |
|
+1.60% | +8.55% |
06-25 | Oppenheimer Initiates Clearside Biomedical at Outperform With $5 Price Target | MT |
05-13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.55% | 91.92M | |
+15.58% | 122B | |
+16.60% | 113B | |
+17.55% | 26.22B | |
-24.33% | 19.01B | |
-19.14% | 15.71B | |
-17.95% | 15.22B | |
-46.81% | 14.72B | |
+58.78% | 14.58B | |
+4.91% | 13.84B |
- Stock Market
- Equities
- CLSD Stock
- News Clearside Biomedical, Inc.
- Transcript : Clearside Biomedical, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-16-2020 11